NCT00101621View on ClinicalTrials.gov

Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain

PHASE2TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

August 31, 2005

Conditions
CancerPain
Interventions
DRUG

M40403

Sponsors
All Listed Sponsors
lead

MetaPhore Pharmaceuticals

INDUSTRY